News
The AHA Aug. 27 said the Health Resources and Services Administration should abandon its 340B Rebate Model Pilot Program.
Just days and weeks away from key deadlines, the hospital industry’s leading trade organization is still calling for the administration to scrap a one-year pilot of drugmakers’ preferred approach t | ...
New York hospitals that participate in 340B should be required to publicly report how much revenue they generate from the ...
Legislation that could change the 340B program should be done so with caution, as the federal program acts as a boon to care for patients with HIV, experts argue.
Misguided eligibility standards and loopholes have allowed 340B hospitals and their associated pharmacies to prioritize profits over patients.
The 340B drug pricing program, originally intended to help low-income and uninsured patients, has been exploited by special interests for profit, resulting in higher drug prices, taxes, and premium… ...
KEY TAKEAWAYS HRSA is launching a voluntary pilot program to test a rebate model for certain 340B drugs, a significant shift from the program's traditional upfront discount structure.
The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992 ...
The 340B program is an existing program that allows certain eligible hospitals and other providers to purchase outpatient drugs at a discount from pharmaceutical manufacturers.
Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues.
The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results